Mandate

Vinge advises PulPac in conjunction with investment

Vinge has advised PulPac AB in connection with an investment in the aggregate amount of MEUR 31 from strategic partners Aliaxis, Stora Enso, Amcor Ventures and Teseo Capital. Existent owners, including cornerstone investor WPP, have also participated in the equity raise.

PulPac has developed a way to manufacture materials and products similar to plastics including, among other things, packaging, using paper as a raw material instead of plastic, so-called Dry Molded Fiber, in a process which requires far less water than previous methods. The company was founded in 2018, employs approximately 70 people and is based in Gothenburg.

Vinge’s team primarily consisted of Kristian Ford, Sofie Nordgren, Carl Trolle Olsson, Lisa Bourghardt and Karin Gynnerstedt.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025